此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Study Evaluating the Effect of Transcranial Direct Current Stimulation (tDCS) Targeting the Right Inferior Frontal Gyrus on Inhibitory Control in Patients With PSP (TinPSP)

2026年9月9日 更新者:Nantes University Hospital

A Double-blind, Randomized, Sham-controlled, Crossover Pilot Study Evaluating the Effect of Transcranial Direct Current Stimulation (tDCS) Targeting the Right Inferior Frontal Gyrus on Inhibitory Control in Patients With PSP.

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease with a prevalence estimated at 6 per 100,000 in France and a rapidly progressive course. In its classic form (known as the Richardson type), it presents with a predominantly axial Parkinsonian syndrome, postural instability with early falls, oculomotor disorders, and cognitive and behavioral disturbances. Apart from levodopa, which may provide a modest improvement in Parkinsonian syndrome in some patients, the current therapeutic approach relies primarily on rehabilitation techniques, with no proven efficacy.

Cognitive-behavioral symptoms are common in this disease and are primarily characterized by impaired executive functions, linked to dysfunction of the frontal cortex. They often have a devastating effect on quality of life, are associated with an increased risk of falls, and represent a considerable burden for caregivers. Among these symptoms, apathy is the most commonly described symptom. Impulsivity, associated with impaired inhibitory control, is present in 32-74% of cases and may coexist with apathy.

Cognitive and behavioral inhibition depends on a complex brain network that includes, among others, the right inferior frontal gyrus (IFG), the dorsolateral prefrontal cortex, the supplementary motor area, the motor cortex, and the basal ganglia. It has recently been shown that patients with PSP have impaired functional connectivity between the right LFC and other brain structures in the network, and that neurotransmitter deficits in the right LFC correlate with their impulsivity Alongside pharmacological approaches, non-invasive brain stimulation techniques are rapidly expanding as a potential therapeutic tool. Transcranial direct current stimulation (tDCS), by modulating cortical excitability, is a promising technique. It is simple to administer and has demonstrated efficacy in several clinical settings.

Furthermore, a recent meta-analysis of 45 clinical studies shows that single or repeated tDCS sessions could modestly but significantly improve the inhibitory response-measured by reaction time in the stop-signal paradigm-especially when active (anodal) stimulation was applied to the right GFI. These studies primarily involved healthy subjects. A few studies have examined the effects of tDCS in neurodegenerative diseases and in PSP. These studies are still preliminary, involving small sample sizes, but are encouraging. Among these, a randomized study comparing tDCS to sham tDCS demonstrated a beneficial effect of a single-session tDCS session targeting the dorsolateral prefrontal cortex on verbal fluency in patients with PSP.

The hypothesis of our study is that applying tDCS stimulation over the right GFI will improve certain cognitive functions and reduce behavioral impulsivity in patients.

Very little data on tDCS in PSP is available to date. Only three studies have been published. With very different designs-including only one randomized trial comparing tDCS to sham tDCS-these studies evaluated the effects of tDCS applied to the dorsolateral prefrontal cortex or to motor and premotor areas on language and motor symptoms, respectively.

In this randomized, double-blind, controlled study, the investigators propose to explore the effects of tDCS on the right GFI on executive functions and, more specifically, on inhibitory control. Another strength of our study is that only patients with proven frontal cerebral hypometabolism on FDG-PET-MRI will be included, which will allow us to test the effect of tDCS on a clearly dysfunctional neural network. Furthermore, as a secondary objective, the investigators will be able to assess whether the effects of tDCS depend on the intensity and/or topography of cerebral hypometabolism.

The neurophysiological effects of a single tDCS session appear to last up to 60 to 90 minutes. In this proof-of-concept study, the assessment tests were deliberately chosen for their short administration time and low test-retest effect. Finally, the Stop Signal Test, already used in this population, is widely used and well-standardized.

This pilot study will provide initial data on the cognitive and motor effects of a tDCS session on the GFI, with a focus on inhibition. Given the limited effectiveness of symptomatic treatments-particularly pharmacological ones-having a new option capable of improving cognitive and/or behavioral performance would have a significant impact on the quality of life of patients and their families. tDCS has the advantage of being easily accessible and generally well-tolerated by patients and could eventually be administered in patients' homes.

If our study demonstrates an improvement in certain cognitive/motor functions, it would lead to a larger-scale study with repeated sessions to assess its benefits over a longer period.

Finally, if an improvement in executive functions is demonstrated in PSP, this could apply to other neurodegenerative diseases.

研究概览

研究类型

介入性

注册 (估计的)

20

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Aged 40 to 89 years
  • Patients with probable PSP according to the MDS-9 diagnostic criteria
  • BREF score >10;
  • 18-FDG PET-MRI performed no more than 6 months prior to enrollment and showing:

    • Glucose hypometabolism defined as > 2.5 SD compared to an atlas of healthy subjects and
    • No severe right frontal cortical atrophy according to F Pasquier's global cortical atrophy scale 53
  • Concomitant treatments must have been stable for at least 4 weeks prior to enrollment and must remain stable throughout participation
  • Patient must have provided written informed consent
  • Patient must be enrolled in a social security program
  • Patient must be able to understand French and comply with the protocol
  • Women must use adequate contraceptive measures for the duration of the clinical trial (in accordance with CTFG recommendations)

Exclusion Criteria:

  • Left-handed Patients;
  • Patients with severe apraxia that interferes with performance of the SST (at the investigator's discretion)
  • Known visual or hearing impairment that prevents performance of cognitive tests or the stop-signal test;
  • History of severe psychiatric or neurological disorders other than PSP;
  • Known significant brain injury(ies) (stroke, tumor, inflammation, post-traumatic, etc.), at the investigator's discretion
  • Atrophy of the right frontal lobe ≥3 on the F Pasquier Global Cortical Atrophy Scale 53
  • History of epilepsy and seizures (or cerebral impairment with unexplained loss of consciousness), severe cardiac disorders, neurosurgical procedures, or severe or frequent headaches;
  • Presence of a cardiac, neural, drug-delivery, or cerebral stimulator
  • Presence of cerebral medical devices (such as vascular clips or electronically sensitive devices), intracerebral or intracochlear metal implants,
  • Patients with any electrically, magnetically, or mechanically activated implant
  • Patients suffering from a serious, life-threatening condition such as congestive heart failure, chronic obstructive pulmonary disease (COPD), or active neoplasia
  • Patients with skin conditions (dermatitis, psoriasis, or eczema) or lesions on the scalp or skull that preclude tDCS
  • Patients under legal guardianship or protective supervision
  • Pregnant or breastfeeding women
  • For patients in the ancillary study, contraindication to MRI: Presence of metallic foreign bodies

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
其他:tDCS Active (first visit) + tDCS sham (second visit)
Each participant will receive active tDCS then sham tDCS during two 20-minute sessions spaced one month apart
Each participant will receive both active tDCS and sham tDCS during two 20-minute sessions spaced one month apart, with the order of the sessions determined at random.
其他:sham tDCS (fist visit) + active tDCS (second visit)
Each participant will receive sham tDCS then active tDCS during two 20-minute sessions spaced one month apart
Each participant will receive both active tDCS and sham tDCS during two 20-minute sessions spaced one month apart, with the order of the sessions determined at random.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
To evaluate the effect of anodal tDCS targeting the right inferior frontal gyrus (IFG) on a motor-modality cognitive inhibition task, the Stop Signal Task (SST), in patients with PSP.
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Stop Signal Reaction Time (SSRT) during the SST (seconds)
during the hour before each tDCS session and within 1 hour after each tDCS session

次要结果测量

结果测量
措施说明
大体时间
To evaluate, in PSP, the effect of anodal tDCS targeting the right GFI on the components of cognitive inhibition assessed by the SST
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) regarding the components of cognitive inhibition in the stop-signal test: reaction time (seconds), number of failed inhibitions, and number of unresponded-to Go stimuli will be combined to obtain a grade (low/high)
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, within the PSP, the effect of anodal tDCS targeting the right GFI on scores on the following neuropsychological assessments of verbal cognitive inhibition
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the Color Word Interference test from the Delis Kaplan Executive System (or Stroop D-KEFS)(scale: Preserved executive functions-Difficulty adapting to novelty)
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, within the PSP, the effect of anodal tDCS targeting the right GFI on scores on the following neuropsychological assessments of perseverative motor behavior
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) regarding the presence or absence of an applause sign and the presence or absence of palilalia
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, within the PSP, the effect of anodal tDCS targeting the right GFI on scores on the following neuropsychological assessments of other executive functions
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the Phonological and Categorical Verbal Fluency Test-which measures perseverations and clusters-and the Symbol-Digit Modality Test.
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, within the PSP, the effect of anodal tDCS targeting the right GFI on scores on the following neuropsychological assessments of social cognition
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the modified Ekman Emotion Recognition Test (6 emotions).
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, within the PSP, the effect of anodal tDCS targeting the right GFI on scores on the following neuropsychological assessments of overall cognitive efficiency
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the MoCA
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate, in the PSP, the effect of anodal tDCS targeting the right GFI on motor and bulbar symptoms
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the PSP-RS scale subscores (ocular motility, bulbar examination, limb examination, gait examination)
during the hour before each tDCS session and within 1 hour after each tDCS session
To evaluate the effect of anodal tDCS targeting the right GFI on motor function in PSP
大体时间:during the hour before each tDCS session and within 1 hour after each tDCS session
Results for each of the two conditions (active / sham) on the Timed Up and Go Test
during the hour before each tDCS session and within 1 hour after each tDCS session
To analyze the effects of tDCS on brain metabolism patterns as assessed by 18-FDG PET-MRI
大体时间:before and after each tDCS session
Effect of tDCS as described in Sections 3 and 4 and the brain binding pattern of the FDG tracer in PET-MRI
before and after each tDCS session
To evaluate the clinical effects of tDCS on patients' clinical characteristics
大体时间:Baseline, before and after each tDCS session
Effect of tDCS as described in Sections 3 and 4, and baseline scores on the PSP-RS scales
Baseline, before and after each tDCS session
To evaluate the clinical effects of tDCS on patients' clinical characteristics
大体时间:Baseline, before and after each tDCS session
Effect of tDCS as described in Sections 3 and 4, and baseline scores on the BREF scales
Baseline, before and after each tDCS session
To evaluate the clinical effects of tDCS on patients' clinical characteristics
大体时间:Baseline, before and after each tDCS session
Effect of tDCS as described in Sections 3 and 4, and baseline scores on the NPI scale
Baseline, before and after each tDCS session
Assess participants' perception and acceptance of tDCS stimulation
大体时间:within 1 hour after each tDCS session
Number and severity of targeted symptoms (itching, burning, pain, etc.) based on the structured questionnaire developed by Antal et al.40
within 1 hour after each tDCS session
Safety Assessment
大体时间:within 1 hour after each tDCS session
Number of EI and Defects
within 1 hour after each tDCS session
Safety Assessment
大体时间:within 1 hour after each tDCS session
Grades of EI and Defects
within 1 hour after each tDCS session

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年9月15日

初级完成 (估计的)

2028年7月15日

研究完成 (估计的)

2028年7月15日

研究注册日期

首次提交

2026年7月7日

首先提交符合 QC 标准的

2026年9月9日

首次发布 (实际的)

2026年9月14日

研究记录更新

最后更新发布 (实际的)

2026年9月14日

上次提交的符合 QC 标准的更新

2026年9月9日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅